Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04241341 · ClinicalTrials.gov registry record · Phase 3
Does Immediate Lymphatic Reconstruction Decrease the Risk of Lymphedema After Axillary Lymph Node Dissection
A Phase 3 study of Breast Cancer Lymphedema, sponsored by Memorial Sloan Kettering Cancer Center.
- Active
- Registry status
- Phase 3
- Development phase
- 180
- Enrollment target
- 7
- Study locations
NCT04241341 is a Phase 3 study of Breast Cancer Lymphedema that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 180 participants. The trial reports 7 study locations across 2 states.
The verdict
NCT04241341, a Phase 3 study of Breast Cancer Lymphedema, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 3
- Development phase
- 180 participants
- Enrollment target
- 7
- Study locations
Study Summary
The researchers are doing this study to see if having immediate lymphatic reconstruction after axillary lymph node dissection (ALND) can decrease the development of lymphedema, a side effect of ALND. Other purposes of the study include: Comparing the approach of immediate lymphatic reconstruction after ALND with the approach of ALND alone Looking at whether having immediate lymphatic reconstruction after ALND improves a person's quality of life Seeing if adding standard of care radiation therapy to either study approach (immediate lymphatic reconstruction after ALND or ALND alone) has an effect on development of lymphedema
Conditions Studied
Interventions
- PROCEDURE Axillary Lymph Node Dissection with Immediate Lymphatic Reconstruction
- PROCEDURE Axillary Lymph Node Dissection without Immediate Lymphatic Reconstruction
- OTHER quality-of-life questionnaires
- OTHER measured by arm volume
Study Locations (7)
New York
- Memorial Sloan Kettering Commack (Consent only) - Commack
- Memorial Sloan Kettering Westchester (Consent Only) - Harrison
- Memorial Sloan Kettering Cancer Center - New York
- Memorial Sloan Kettering Nassau (Consent only) - Uniondale
New Jersey
- Memorial Sloan Kettering Basking Ridge (Consent and Followup) - Basking Ridge
- Memorial Sloan Kettering Monmouth (Consent Only) - Middletown
- Memorial Sloan Kettering Bergen (Consent Only) - Montvale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2020-01-22 |
| Est. Completion | 2027-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04241341
The ClinicalTrials.gov registry entry for NCT04241341 describes a study currently listed as active not recruiting, categorized as Phase 3. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Breast Cancer Lymphedema appearing as the primary indexed condition, and to 4 interventions - of which Axillary Lymph Node Dissection with Immediate Lymphatic Reconstruction is the first listed.
NCT04241341 reports 7 study locations spanning 2 distinct geographic areas - top geographies include New York, New Jersey.
Frequently Asked Questions
What is clinical trial NCT04241341 about?
NCT04241341 is a clinical study titled "Does Immediate Lymphatic Reconstruction Decrease the Risk of Lymphedema After Axillary Lymph Node Dissection". The researchers are doing this study to see if having immediate lymphatic reconstruction after axillary lymph node dissection (ALND) can decrease the development of lymphedema, a side effect of ALND. Other purposes of the study include: Comparing the approach of immediate lymphatic reconstruction a...
What is the current status of trial NCT04241341?
This trial is currently active not recruiting. It is a Phase 3 study. The enrollment target is 180 participants. The study started on 2020-01-22. Estimated completion is 2027-01.
What conditions does trial NCT04241341 study?
This clinical trial studies the following conditions: Breast Cancer Lymphedema.
What interventions are being tested in trial NCT04241341?
The interventions under investigation include: Axillary Lymph Node Dissection with Immediate Lymphatic Reconstruction (PROCEDURE), Axillary Lymph Node Dissection without Immediate Lymphatic Reconstruction (PROCEDURE), quality-of-life questionnaires (OTHER), measured by arm volume (OTHER).
Who is sponsoring clinical trial NCT04241341?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04241341 being conducted?
This trial has 7 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer Lymphedema
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.